A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma
Clinical trial NCT01672736 · TERMINATED
Trial details
- NCT number
- NCT01672736
- Sponsor
- University Health Network, Toronto
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2017-03-27
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.